India gains as Big Pharma looks beyond China

Drugmakers are reducing their reliance on Chinese contractors and turning to manufacturers in India for clinical trials and early-stage manufacturing, as tensions with China and concerns over supply chain exposure increase.

Related Keywords

United States ,India ,Shanghai ,China ,London ,City Of ,United Kingdom ,Hyderabad ,Andhra Pradesh ,Chinese ,Ramesh Subramanian ,Catherine Evans ,Andrew Silver ,Rishika Sadam ,Tommy Erdei ,Piramal Pharma ,Peter Deyoung ,Indian Cdmos ,Helen Chen ,Maggie Fick ,Ashish Nimgaonkar ,Michele Gershberg ,Drug Administration ,Piramal Pharma Solutions ,Aragen Life Sciences ,Sai Life Sciences ,Reuters ,Glyscend Therapeutics ,Greater China Managing Partner ,Mordor Intelligence ,Life Sciences ,Big Pharma ,